Worthington Industries, Inc. has announced a price increase on all Life Sciences Cryogenic products distributed globally.

The price increases will be effective on all orders placed on or after 1st January (2020), or as contracts allow.

“Increasing costs associated with changing global market dynamics have forced us to make pricing adjustments to offset these inflationary pressures,” said Josh Oakes, Director of Cryogenics for Worthington Industries.

Worthington, which is headquartered in Columbus, Ohio, is a diversified metals manufacturing company with 2019 fiscal year net sales of $3.8bn.